Attention: Phase III Results Are Coming

Reportedly, $ELTP is readying to release the Phase III results for testing their ELI200 ART. This drug has been in its Human Abuse Liability Study phase. Waiting for these results has, as can be expected, raised speculative brows as investors stake their claim. I've seen promises of $4.00 and .02 (and most everything in between) by chat-board warriors. Meanwhile, the company has recently recorded record revenues but the stagnation of the share price continues to inflame the rumors. Stay tuned, things are bound to get interesting, one way or another, before too long. Here's hoping for the best....